22157.jpg
Global DNA/RNA Extraction Kit Market Research Report 2021-2026: Increasing Investments in Research and Development of Molecular Diagnostics Driving Growth
August 11, 2021 04:48 ET | Research and Markets
Dublin, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The "DNA/RNA Extraction Kit Market - Growth, Trends, COVID-19 Impact, and Forecast (2021 - 2026)" report has been added to ResearchAndMarkets.com's...
22157.jpg
Circulating DNA/RNA Patent Landscape Report 2021: Oppositions and Litigations, Key Patent Analysis, Patent Database
July 05, 2021 06:53 ET | Research and Markets
Dublin, July 05, 2021 (GLOBE NEWSWIRE) -- The "Circulating DNA/RNA Patent Landscape 2021" report has been added to ResearchAndMarkets.com's offering. Circulating nucleic acids tests, an essential...
Inivata_CMYK_Logo.jpg
Inivata to Present Data at AACR Virtual Annual Meeting Highlighting Capabilities and Clinical Application of RaDaR™ Assay
June 22, 2020 09:32 ET | Inivata
Inivata to Present Data at AACR Virtual Annual Meeting Highlighting Capabilities and Clinical Application of RaDaR™ Assay Personalized assay for detection of residual disease and recurrence...
PRPO logo.png
Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues
October 16, 2018 07:47 ET | Precipio, Inc.
Fourth consecutive Quarter of Triple-Digit Year-over-Year Quarterly Revenue Growth; Year-to-Date Revenues Increased 163% over First Three Quarters of 2017 NEW HAVEN, Conn., Oct. 16, 2018 (GLOBE...
PRPO logo.png
Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology
June 06, 2018 07:38 ET | Precipio, Inc.
NEW HAVEN, Conn., June 06, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced the award of US patent No. 9,957,556 entitled FULL COLD-PCR...
Exosome Diagnostics Launches the MedOncAlyzer™ Pan-Cancer Panel
August 09, 2017 09:02 ET | Exosome Diagnostics
Waltham, Mass., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, a leader in the liquid biopsy market, today announced the launch of the MedOncAlyzer 170, the first liquid biopsy pan-cancer...
Breakthrough Technology Spurs New Test for Non-Small Cell Lung Cancer Patients
November 05, 2015 15:18 ET | ARUP Laboratories
SALT LAKE CITY, Nov. 5, 2015 (GLOBE NEWSWIRE) -- For a patient battling lung cancer, the discomforts and risks of undergoing repeated biopsies, surgeries, and radiologic scans can now be replaced by a...